Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Médicréa International    ALMED   FR0004178572

MÉDICRÉA INTERNATIONAL (ALMED)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Medicrea International : Files a Lawsuit against K2M Spine, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 07:41pm CEST

The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD™ Adaptive Spine Intelligence (“ASI”) technology, announces that on Wednesday, November 8th, 2017, Medicrea USA, Inc., filed a lawsuit in the United States District Court for the Southern District of New York against K2M Spine, Inc. and several other defendants. The case has been assigned to the Honorable Analisa Torres, District Judge.

The lawsuit addresses the unlawful acts that K2M and the other defendants have taken over the course of the past year.

Medicrea has revolutionized spinal surgery through our innovative UNID™ technology, the first and only patient-specific spinal rod approved for use in the United States.

We will aggressively pursue all available legal rights to protect our market-leading business.

About Medicrea (www.Medicrea.com)

Through the lens of predictive medicine, Medicrea leads the design, integrated manufacture, and distribution of 30+ FDA approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. By leveraging its proprietary software analysis tools with big data and machine learning technologies and supported by an expansive collection of clinical and scientific data, Medicrea is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.

Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 175 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.

For further information, please visit: Medicrea.com.

Connect with Medicrea:

FACEBOOK | INSTAGRAM | TWITTER | WEBSITE | YOUTUBE

Medicrea is listed on

EURONEXT Growth Paris

ISIN: FR 0004178572

Ticker: ALMED

LEI: 969500BR1CPTYMTJBA37


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MÉDICRÉA INTERNATIONAL
10/11MEDICREA INTERNATIONAL : Third Quarter 2018 Sales
BU
10/10MEDICREA INTERNATIONAL : Leading into SRS 2018, Medicrea Highlights a New Study ..
BU
10/08MEDICREA INTERNATIONAL SA : quaterly sales release
09/27MEDICREA : Hosts First-Ever Spine Artificial Intelligence Focused Meeting in Lyo..
BU
09/26MEDICREA : Announces NASS 2018 Presence And Highlights a Recently Published Stud..
BU
09/20MEDICREA : Announces Eurospine 2018 Presence and Highlights a Recently Published..
BU
09/19MEDICREA : Reports First Half 2018 Results
BU
09/13MEDICREA INTERNATIONAL SA : half-yearly earnings release
08/27MEDICREA : to Begin Trading on the OTCQX Market in the U.S.
BU
07/10MEDICREA : Partners with Leading National Spine Distributor to Launch Australian..
BU
More news
Chart MÉDICRÉA INTERNATIONAL
Duration : Period :
Médicréa International Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MÉDICRÉA INTERNATIONAL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers
NameTitle
Denys Sournac Chairman & Chief Executive Officer
David Ryan Chief Operating Officer
Fabrice Kilfiger CFO & Investor Relations Officer
Thomas Mosnier Chief Scientific Officer
Jean-Philippe Caffiero Director & Deputy Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
MÉDICRÉA INTERNATIONAL-34.33%37
STRYKER CORPORATION10.46%63 967
SMITH & NEPHEW-0.54%14 734
WRIGHT MEDICAL GROUP NV21.89%3 350
GLAUKOS CORP133.18%2 075
JAPAN LIFELINE CO., LTD.-12.81%1 692